Company Overview of Elcelyx Therapeutics, Inc.
Elcelyx Therapeutics, Inc. develops new therapies and re-positions existing therapies to meet serious unmet needs. Its development portfolio includes Metformin DR, a delayed-release formulation of metformin that releases metformin primarily in the distal small intestine and restricts metformin to the bowel primarily suited for patients who cannot use metformin owing to contraindications or poor tolerability. The company’s Metformin DR solution serves as an initial agent for the treatment of type 2 diabetes. The company was incorporated in 2009 and is headquartered in San Diego, California.
11975 El Camino Real
San Diego, CA 92130
Founded in 2009
Key Executives for Elcelyx Therapeutics, Inc.
Elcelyx Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Onset Dermatologics LLC||United States|
|Suneva Medical, Inc.||United States|
|Mt. Cook Pharma, Inc.||United States|
|Vitaline Corporation||United States|
|EvoGenix, Inc.||United States|
Recent Private Companies Transactions
September 25, 2015
To contact Elcelyx Therapeutics, Inc., please visit elcelyx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.